Breast Cancer Episode 15: 5-Year Follow-Up of Abemaciclib Plus Endocrine Therapy in High-Risk HR+/HER2- Early Breast Cancer – Insights from the MonarchE Study 15 February 2024
GI Episode 6: Fruquintinib, a new drug in refractory, metastatic colorectal cancer: results from the FRESCO-2 trial 14 February 2024
Lung Cancer Episode 3: Adjuvant Pembrolizumab for Early-Stage NSCLC After Resection and Optional Chemotherapy: the PEARLS trial 13 February 2024
